SciELO - Scientific Electronic Library Online

 
vol.74 issue2Change in the drugs administration pattern in the Basque Country community. The 1991-1996 trendJob satisfaction among primary care professionals in Area 10 Insalud, Madrid author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista Española de Salud Pública

On-line version ISSN 2173-9110Print version ISSN 1135-5727

Abstract

CRIADO- ALVAREZ, Juan J; DOMPER TORNIL, Jaime A  and  ROSA RODRIGUEZ, Gloria de la. Estimate of type I bipolar disorder prevalence (1996-1998). Rev. Esp. Salud Publica [online]. 2000, vol.74, n.2, pp.00-00. ISSN 2173-9110.

BACKGROUND: Different methodologies have been employed for conducting the few studies made on the prevalence of Type I Bipolar Disorders, which makes it impossible to know what impact these disorders have had on public health in Spain. The prevalence of Type I Bipolar Disorders is calculated by the degree to which lithium carbonate is used. METHODS: The prevalence is estimated by calculating the daily doses of lithium carbonate prescribed per 100,000 inhabitants/day (Treatment Group, NO5AN) throughout the 1996-1998 period for each one of the provinces in Spain. The data based on the prescriptions written was provided by the Pharmaceutical Planning Bureau of the Ministry of Health and Consumer Affairs. RESULTS: A prevalence of 70 cases/1000,000 inhabitants/day for the overall population of Spain was estimated. CONCLUSIONS: Lithium carbonate usage by provinces and by years affords the possibility of estimating the distribution of Type I Bipolar Disorders in Spain. The figures calculated rank Spain at a low-average prevalence, although the methodological differences prevent it from being possible to draw any final conclusions.

Keywords : Bipolar disorders; Lithium; Drug epidemiology; Prevalence; Daily Dose Defined.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License